Rezolute (RZLT) Other Gross PP&E Adjustments (2013 - 2026)
Rezolute recorded quarterly Other Gross PP&E Adjustments of -$918000.0 in Q1 2026, up 19.61% quarter-over-quarter from -$1.1 million in Q4 2025, and up 38.18% year-over-year from -$664342.1 in Q1 2025.
Rezolute's Other Gross PP&E Adjustments history runs 14 years deep, the most recent figure standing at -$918000.0 for Q1 2026.
- In Q1 2026, Other Gross PP&E Adjustments rose 38.18% year-over-year to -$918000.0; the TTM figure through Mar 2026 stood at -$918000.0 (up 38.18% YoY), while the FY2025 annual figure was -$6.8 million, down 14.08% from the prior year.
- Other Gross PP&E Adjustments came in at -$918000.0 for Q1 2026 at Rezolute, up from -$1.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$186000.0 in Q1 2022 to a low of -$6.8 million in Q2 2025.
- A 5-year average of -$2.4 million and a median of -$1.9 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Across the five-year window, Other Gross PP&E Adjustments soared 75.36% in 2022 and tumbled 1438.17% in 2023, its largest moves.
- Rezolute's Other Gross PP&E Adjustments stood at -$2.4 million in 2022, then climbed by 11.36% to -$2.1 million in 2023, then climbed by 23.99% to -$1.6 million in 2024, then gained by 29.46% to -$1.1 million in 2025, then grew by 19.61% to -$918000.0 in 2026.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$918000.0, -$1.1 million, and -$1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -918,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -918,000.00 |
| Mar 31, 2026 | -918,000.00 |
| Dec 31, 2025 | -1.14 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -6.79 Mn |
| Jun 30, 2025 | -6.79 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Mar 31, 2025 | -1.49 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -5.95 Mn |
| Jun 30, 2024 | -5.95 Mn |
| Mar 31, 2024 | -2.01 Mn |
| Mar 31, 2024 | -2.01 Mn |
| Dec 31, 2023 | -2.13 Mn |
| Dec 31, 2023 | -2.13 Mn |
| Sep 30, 2023 | -1.93 Mn |
| Sep 30, 2023 | -1.93 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Jun 30, 2023 | -4.73 Mn |
| Mar 31, 2023 | -2.86 Mn |
| Mar 31, 2023 | -2.86 Mn |
| Dec 31, 2022 | -2.40 Mn |
| Dec 31, 2022 | -2.40 Mn |
| Sep 30, 2022 | -218,000.00 |
| Sep 30, 2022 | -218,000.00 |
| Jun 30, 2022 | -2.82 Mn |
| Jun 30, 2022 | -2.82 Mn |
| Mar 31, 2022 | -186,000.00 |
| Mar 31, 2022 | -186,000.00 |
| Dec 31, 2021 | -354,000.00 |
| Dec 31, 2021 | -354,000.00 |
| Sep 30, 2021 | -509,000.00 |
| Sep 30, 2021 | -509,000.00 |
| Jun 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.34 Mn |
| Mar 31, 2021 | -755,000.00 |
| Mar 31, 2021 | -755,000.00 |
| Dec 31, 2020 | -626,000.00 |
| Dec 31, 2020 | -626,000.00 |
| Sep 30, 2020 | -495,000.00 |
| Sep 30, 2020 | -495,000.00 |
| Jun 30, 2020 | -4.93 Mn |
| Jun 30, 2020 | -4.93 Mn |
| Mar 31, 2020 | -646,000.00 |
| Mar 31, 2020 | -646,000.00 |
| Dec 31, 2019 | -667,000.00 |
| Dec 31, 2019 | -667,000.00 |
| Sep 30, 2019 | -620,000.00 |
| Sep 30, 2019 | -620,000.00 |
| Jun 30, 2019 | -3.67 Mn |
| Jun 30, 2019 | -3.67 Mn |
| Mar 31, 2019 | 40,615.00 |
| Mar 31, 2019 | 40,615.00 |
| Sep 30, 2018 | 537,562.00 |
| Sep 30, 2018 | 537,562.00 |
| Jun 30, 2018 | -3.28 Mn |
| Jun 30, 2018 | -3.28 Mn |
| Mar 31, 2018 | 7.32 Mn |
| Mar 31, 2018 | 7.32 Mn |
| Dec 31, 2017 | 7.32 Mn |
| Dec 31, 2017 | 7.32 Mn |
| Sep 30, 2017 | 7.32 Mn |
| Sep 30, 2017 | 7.32 Mn |
| Jun 30, 2017 | 7.31 Mn |
| Jun 30, 2017 | 7.31 Mn |
| Mar 31, 2017 | 7.17 Mn |
| Mar 31, 2017 | 7.17 Mn |
| Dec 31, 2016 | 7.15 Mn |
| Dec 31, 2016 | 7.15 Mn |
| Sep 30, 2016 | 7.05 Mn |
| Sep 30, 2016 | 7.05 Mn |
| Jun 30, 2016 | 6.86 Mn |
| Jun 30, 2016 | 6.86 Mn |
| Mar 31, 2016 | 6.75 Mn |
| Mar 31, 2016 | 6.75 Mn |
| Dec 31, 2015 | 6.43 Mn |
| Dec 31, 2015 | 6.43 Mn |
| Sep 30, 2015 | 5.70 Mn |
| Sep 30, 2015 | 5.70 Mn |
| Jun 30, 2015 | 4.66 Mn |
| Jun 30, 2015 | 4.66 Mn |
| Jun 30, 2014 | 345,691.00 |
| Jun 30, 2014 | 345,691.00 |
| Mar 31, 2014 | 275,717.00 |
| Mar 31, 2014 | 275,717.00 |
| Dec 31, 2013 | 275,717.00 |
| Dec 31, 2013 | 275,717.00 |
| Sep 30, 2013 | 275,717.00 |
| Sep 30, 2013 | 275,717.00 |
| Jun 30, 2013 | 275,717.00 |
| Jun 30, 2013 | 275,717.00 |
| Mar 31, 2013 | 275,717.00 |
| Mar 31, 2013 | 275,717.00 |